• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NGM
    11.04 Up 0.62(5.95%) Dec 19, 4:00PM EST
    |After Hours : 11.04 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (130,925) (91,277) (79,223)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation2,589  3,664  4,596  
    Adjustments To Net Income15,860  6,380  7,816  
    Changes In Accounts Receivables1,601  (4,195)(3,681)
    Changes In Liabilities8,315  1,704  20,778  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities7,145  4,385  (2,650)
    Total Cash Flow From Operating Activities (95,175) (79,816) (52,817)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(9,857)(3,189)(3,754)
    Investments(17,823)(71,785) -  
    Other Cash flows from Investing Activities(59)(247)7  
    Total Cash Flows From Investing Activities (27,739) (75,221) (3,747)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(3)(4,235) -  
    Sale Purchase of Stock28,752  105,452  78,694  
    Net Borrowings121,537  41,080  (443)
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 150,286   142,297   76,305  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 27,372   (12,740) 19,741  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.